Clinical Trials Browser

Phase NA × INDUSTRY × Burkitt Lymphoma × Clear all

NCT06890065 2025-05-15

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

Phase NA Recruiting

Burkitt Lymphoma